Introduction: Myocardial infarction (MI) is the leading cause of death all over the world. The pivotal roles of Phospholipase C like 2 gene (PLCL2) in calcium homeostasis and immune responses make this gene as a potential candidate for its role in MI pathogenesis. The present study was undertaken to investigate whether rs4618210A>G polymorphism in PLCL2 gene contribute to MI etiology. Methods: A hospital-based case-control study with 600 subjects, including 300 MI patients and 300controls, was conducted. Genotyping of PLCL2 rs4618210 polymorphism was performed using amplification refractory mutation system-polymerase chain reaction (ARMS PCR) method. Data were analyzed using logistic regression analysis. Results: No significant association was found between the PLCL2 rs4618210 alleles and MI risk.However, a significantly increased risk of MI was observed among carriers of the AG genotype (OR= 1.91; 95% CI = 1.24 - 2.93; P = 0.003) compared with AA homozygote. In a dominant mode of inheritance for G allele (GG + AG vs. AA), the frequency of the carriers of at least one G allele was higher in cases compared to controls (OR= 1.56; 95% CI: 1.03 - 2.36; P = 0.037). Conclusion: Our study provided further evidence that PLCL2 gene polymorphism may serve as a prognostic marker for MI.
Introduction: Myocardial infarction (MI) is the leading cause of death all over the world. The pivotal roles of Phospholipase C like 2 gene (PLCL2) in calcium homeostasis and immune responses make this gene as a potential candidate for its role in MI pathogenesis. The present study was undertaken to investigate whether rs4618210A>G polymorphism in PLCL2 gene contribute to MI etiology. Methods: A hospital-based case-control study with 600 subjects, including 300 MI patients and 300controls, was conducted. Genotyping of PLCL2rs4618210 polymorphism was performed using amplification refractory mutation system-polymerase chain reaction (ARMS PCR) method. Data were analyzed using logistic regression analysis. Results: No significant association was found between the PLCL2rs4618210 alleles and MI risk.However, a significantly increased risk of MI was observed among carriers of the AG genotype (OR= 1.91; 95% CI = 1.24 - 2.93; P = 0.003) compared with AA homozygote. In a dominant mode of inheritance for G allele (GG + AG vs. AA), the frequency of the carriers of at least one G allele was higher in cases compared to controls (OR= 1.56; 95% CI: 1.03 - 2.36; P = 0.037). Conclusion: Our study provided further evidence that PLCL2 gene polymorphism may serve as a prognostic marker for MI.
Authors: George F Mells; James A B Floyd; Katherine I Morley; Heather J Cordell; Christopher S Franklin; So-Youn Shin; Michael A Heneghan; James M Neuberger; Peter T Donaldson; Darren B Day; Samantha J Ducker; Agnes W Muriithi; Elizabeth F Wheater; Christopher J Hammond; Muhammad F Dawwas; David E Jones; Leena Peltonen; Graeme J Alexander; Richard N Sandford; Carl A Anderson Journal: Nat Genet Date: 2011-03-13 Impact factor: 38.330
Authors: Lam C Tsoi; Sarah L Spain; Eva Ellinghaus; Philip E Stuart; Francesca Capon; Jo Knight; Trilokraj Tejasvi; Hyun M Kang; Michael H Allen; Sylviane Lambert; Stefan W Stoll; Stephan Weidinger; Johann E Gudjonsson; Sulev Koks; Külli Kingo; Tonu Esko; Sayantan Das; Andres Metspalu; Michael Weichenthal; Charlotta Enerback; Gerald G Krueger; John J Voorhees; Vinod Chandran; Cheryl F Rosen; Proton Rahman; Dafna D Gladman; Andre Reis; Rajan P Nair; Andre Franke; Jonathan N W N Barker; Goncalo R Abecasis; Richard C Trembath; James T Elder Journal: Nat Commun Date: 2015-05-05 Impact factor: 14.919
Authors: Fatih Uzun; Mehmet Erturk; Huseyin Altug Cakmak; Ali Kemal Kalkan; Ibrahim Faruk Akturk; Ahmet Arif Yalcin; Begum Uygur; Umit Bulut; Kursat Oz Journal: Postepy Kardiol Interwencyjnej Date: 2017-03-10 Impact factor: 1.426